| 000 | 01729 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513150420.0 | ||
| 264 | 0 | _c19981029 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0306-4522 | ||
| 024 | 7 |
_a10.1016/s0306-4522(98)00100-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSallinen, J | |
| 245 | 0 | 0 |
_aD-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype. _h[electronic resource] |
| 260 |
_bNeuroscience _cOct 1998 |
||
| 300 |
_a959-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a5-Hydroxytryptophan _xpharmacology |
| 650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCrosses, Genetic |
| 650 | 0 | 4 |
_aDextroamphetamine _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Targeting |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHomozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedetomidine |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Inbred DBA |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-2 _xgenetics |
| 650 | 0 | 4 |
_aSerotonin _xphysiology |
| 650 | 0 | 4 | _aSex Characteristics |
| 650 | 0 | 4 |
_aStereotypic Movement Disorder _xgenetics |
| 650 | 0 | 4 | _aSyndrome |
| 700 | 1 | _aHaapalinna, A | |
| 700 | 1 | _aViitamaa, T | |
| 700 | 1 | _aKobilka, B K | |
| 700 | 1 | _aScheinin, M | |
| 773 | 0 |
_tNeuroscience _gvol. 86 _gno. 3 _gp. 959-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0306-4522(98)00100-6 _zAvailable from publisher's website |
| 999 |
_c9658385 _d9658385 |
||